Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Nano-Drug Delivery System Targeting the Oxidative Stress Microenvironment: A Prospective Strategy for Intervertebral Disc Degeneration Treatment

Wang Y., Wen P., Zhang BF., Hu S., Yang Z.

Narrative Review on Back Pain, Disc Degeneration, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41030573
PMCID
PMC12478456
DOI
10.2147/ijn.s529127
Citations
1

Abstract (original English)

Intervertebral disc degeneration (IDD) is the main cause of low back pain (LBP), which imposes a heavy burden on individuals and society. At present, the treatment methods for IDD aim to control clinical symptoms, and it is difficult to fundamentally reverse IDD and reconstruct its mechanical function. Related studies have shown that oxidative stress is a key factor in promoting intervertebral disc (IVD) degeneration and impeding its repair, so antioxidant therapy may be effective in improving or reversing IDD progression. However, considering the non-targeted systemic cytotoxicity and limited bioavailability of antioxidant biopharmaceuticals, it is urgent to establish an efficient drug delivery system. With the development and innovation of nanomedicine and materials science, nano-drug delivery systems (NDDSs) have shown broad application prospects in various diseases. Relying on the characteristics of nanoscale materials, NDDSs can achieve good biodegradability, biocompatibility, targeted drug delivery, and controlled drug release, thereby enhancing the efficacy of antioxidant preparations. This review not only summarizes the research progress of NDDSs in the treatment of IDD, but also evaluates the advantages and challenges faced by various NDDSs. We anticipate that the perspectives articulated in this review will offer valuable insights for the precise management of IDD.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansAntioxidantsDrug Delivery SystemsOxidative StressNanomedicineIntervertebral Disc DegenerationNanoparticle Drug Delivery System

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research